Target intelligence / Profile preview

Lymphatic and plasma proteins in lymphatic fluid and lymph node tissue

Molecular classification
Other
01

Overview

Lymphatic and plasma proteins in lymphatic fluid and lymph node tissue refer to the complex mixture of proteins that circulate within the lymphatic system, including plasma-derived proteins that have extravasated from the blood and proteins produced locally by cells within the lymph nodes and vessels (Sarkisyan et al., 2016, Journal of Proteome Research). This proteome is essential for maintaining fluid homeostasis, transporting dietary lipids, and facilitating immune surveillance by carrying antigens and immune cells to secondary lymphoid organs (Dixon, 2010, Lymphatic Research and Biology). While not a single therapeutic target, the lymphatic environment is a critical focus for drug delivery, particularly for vaccines and biologics that require transport to lymph nodes to interact with the immune system (Trevor et al., 2015, Advanced Drug Delivery Reviews). Dysregulation of these proteins is often observed in conditions such as lymphedema, chronic inflammation, and cancer, where the lymphatic system serves as a primary route for metastatic spread (National Cancer Institute, 2023). Understanding the composition and dynamics of these proteins is vital for optimizing the pharmacokinetics of drugs designed for lymphatic uptake.

Other names
Lymphatic proteomeLymph fluid proteinsLymph node proteinsLymphatic system proteins
02

Mechanism of action

Not applicable as this refers to a biological compartment and proteome rather than a single molecular target.

03

Biological functions

Immune responseFluid homeostasisLipid transportAntigen presentationSignal transduction
04

Disease associations

CancerInflammationInfectionLymphedemaAutoimmune disease
05

Safety considerations

Off-target effects due to systemic distributionImpaired lymphatic drainageImmunogenicity of delivered biologicsPotential for lymphatic toxicity
06

Biomarkers

Vascular endothelial growth factor C (VEGF-C)C-C motif chemokine ligand 21 (CCL21)AlbuminImmunoglobulinsAlpha-2-macroglobulin

Beyond the preview

Go deeper on Lymphatic and plasma proteins in lymphatic fluid and lymph node tissue.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lymphatic and plasma proteins in lymphatic fluid and lymph node tissue.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call